SAVR and TAVI comparison across the globe based on current regional registry evidence – A meta-analysis of reconstructed time-to-event data

Background: There is debate whether surgical aortic valve replacement (SAVR) or transcatheter implantation (TAVI) provide better results for treatment of aortic valve stenosis. While randomized clinical trials (RCTs) are considered to compare the average treatment effect of two methods in a selected...

Full description

Saved in:
Bibliographic Details
Main Authors: Tulio Caldonazo, Hristo Kirov, Anna Vogel, Angelique Runkel, Murat Mukharyamov, Johannes Fischer, Aryan Dadashzadeh, Torsten Doenst
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S235290672500106X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850038846470750208
author Tulio Caldonazo
Hristo Kirov
Anna Vogel
Angelique Runkel
Murat Mukharyamov
Johannes Fischer
Aryan Dadashzadeh
Torsten Doenst
author_facet Tulio Caldonazo
Hristo Kirov
Anna Vogel
Angelique Runkel
Murat Mukharyamov
Johannes Fischer
Aryan Dadashzadeh
Torsten Doenst
author_sort Tulio Caldonazo
collection DOAJ
description Background: There is debate whether surgical aortic valve replacement (SAVR) or transcatheter implantation (TAVI) provide better results for treatment of aortic valve stenosis. While randomized clinical trials (RCTs) are considered to compare the average treatment effect of two methods in a selected patient population, registry data, although biased, reflect every day clinical practice and provide external validation of RCTs. We evaluated the impact of SAVR or TAVI on long-term survival based on local reports from all available regions in the world. Methods: We systematically searched three databases selecting risk-adjusted registry studies comparing outcomes for SAVR and TAVI with at least five years of follow-up. Reports without all-cause mortality were excluded. One time-to-event curve was reconstructed from survival curves. Cox regression model and sensitivity analysis were performed. Results: From 10,399 screened studies, 13 met the inclusion criteria with 28,344 patients in the final analysis (follow-up: 5–9 years). In ten studies, survival rates favored SAVR, three showed no difference and none favored TAVI. Hazard ratio (HR) for overall survival was 0.58 (95 %CI: 0.54–0.61, p < 0.01 – favors SAVR). A landmark analysis with a 6-months split showed no significant survival difference in the first 6 months (HR: 0.94, 95 %CI: 0.86–1.02, p = 0.14) and better survival for SAVR compared to TAVI thereafter (HR: 0.43, 95 %CI: 0.40–0.46, p < 0.01). All sensitivity analyses supported this outcome. Conclusions: This systematic regional registry-type comparison revealed that SAVR is associated with increased long-term survival compared to TAVI, which appears to be independent of the world region in which the study was performed.
format Article
id doaj-art-86d7ec03fa0246bba08c124eeb64e17b
institution DOAJ
issn 2352-9067
language English
publishDate 2025-08-01
publisher Elsevier
record_format Article
series International Journal of Cardiology: Heart & Vasculature
spelling doaj-art-86d7ec03fa0246bba08c124eeb64e17b2025-08-20T02:56:29ZengElsevierInternational Journal of Cardiology: Heart & Vasculature2352-90672025-08-015910170310.1016/j.ijcha.2025.101703SAVR and TAVI comparison across the globe based on current regional registry evidence – A meta-analysis of reconstructed time-to-event dataTulio Caldonazo0Hristo Kirov1Anna Vogel2Angelique Runkel3Murat Mukharyamov4Johannes Fischer5Aryan Dadashzadeh6Torsten Doenst7Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, GermanyDepartment of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, GermanyDepartment of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, GermanyDepartment of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, GermanyDepartment of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, GermanyDepartment of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, GermanyDepartment of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, GermanyCorresponding author at: Department of Cardiothoracic Surgery, University of Jena, Am Klinikum 1, 07747 Jena, Germany.; Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, GermanyBackground: There is debate whether surgical aortic valve replacement (SAVR) or transcatheter implantation (TAVI) provide better results for treatment of aortic valve stenosis. While randomized clinical trials (RCTs) are considered to compare the average treatment effect of two methods in a selected patient population, registry data, although biased, reflect every day clinical practice and provide external validation of RCTs. We evaluated the impact of SAVR or TAVI on long-term survival based on local reports from all available regions in the world. Methods: We systematically searched three databases selecting risk-adjusted registry studies comparing outcomes for SAVR and TAVI with at least five years of follow-up. Reports without all-cause mortality were excluded. One time-to-event curve was reconstructed from survival curves. Cox regression model and sensitivity analysis were performed. Results: From 10,399 screened studies, 13 met the inclusion criteria with 28,344 patients in the final analysis (follow-up: 5–9 years). In ten studies, survival rates favored SAVR, three showed no difference and none favored TAVI. Hazard ratio (HR) for overall survival was 0.58 (95 %CI: 0.54–0.61, p < 0.01 – favors SAVR). A landmark analysis with a 6-months split showed no significant survival difference in the first 6 months (HR: 0.94, 95 %CI: 0.86–1.02, p = 0.14) and better survival for SAVR compared to TAVI thereafter (HR: 0.43, 95 %CI: 0.40–0.46, p < 0.01). All sensitivity analyses supported this outcome. Conclusions: This systematic regional registry-type comparison revealed that SAVR is associated with increased long-term survival compared to TAVI, which appears to be independent of the world region in which the study was performed.http://www.sciencedirect.com/science/article/pii/S235290672500106XSurgical aortic valve replacementTranscatheter aortic valve implantationRandomized clinical trialRegistry study
spellingShingle Tulio Caldonazo
Hristo Kirov
Anna Vogel
Angelique Runkel
Murat Mukharyamov
Johannes Fischer
Aryan Dadashzadeh
Torsten Doenst
SAVR and TAVI comparison across the globe based on current regional registry evidence – A meta-analysis of reconstructed time-to-event data
International Journal of Cardiology: Heart & Vasculature
Surgical aortic valve replacement
Transcatheter aortic valve implantation
Randomized clinical trial
Registry study
title SAVR and TAVI comparison across the globe based on current regional registry evidence – A meta-analysis of reconstructed time-to-event data
title_full SAVR and TAVI comparison across the globe based on current regional registry evidence – A meta-analysis of reconstructed time-to-event data
title_fullStr SAVR and TAVI comparison across the globe based on current regional registry evidence – A meta-analysis of reconstructed time-to-event data
title_full_unstemmed SAVR and TAVI comparison across the globe based on current regional registry evidence – A meta-analysis of reconstructed time-to-event data
title_short SAVR and TAVI comparison across the globe based on current regional registry evidence – A meta-analysis of reconstructed time-to-event data
title_sort savr and tavi comparison across the globe based on current regional registry evidence a meta analysis of reconstructed time to event data
topic Surgical aortic valve replacement
Transcatheter aortic valve implantation
Randomized clinical trial
Registry study
url http://www.sciencedirect.com/science/article/pii/S235290672500106X
work_keys_str_mv AT tuliocaldonazo savrandtavicomparisonacrosstheglobebasedoncurrentregionalregistryevidenceametaanalysisofreconstructedtimetoeventdata
AT hristokirov savrandtavicomparisonacrosstheglobebasedoncurrentregionalregistryevidenceametaanalysisofreconstructedtimetoeventdata
AT annavogel savrandtavicomparisonacrosstheglobebasedoncurrentregionalregistryevidenceametaanalysisofreconstructedtimetoeventdata
AT angeliquerunkel savrandtavicomparisonacrosstheglobebasedoncurrentregionalregistryevidenceametaanalysisofreconstructedtimetoeventdata
AT muratmukharyamov savrandtavicomparisonacrosstheglobebasedoncurrentregionalregistryevidenceametaanalysisofreconstructedtimetoeventdata
AT johannesfischer savrandtavicomparisonacrosstheglobebasedoncurrentregionalregistryevidenceametaanalysisofreconstructedtimetoeventdata
AT aryandadashzadeh savrandtavicomparisonacrosstheglobebasedoncurrentregionalregistryevidenceametaanalysisofreconstructedtimetoeventdata
AT torstendoenst savrandtavicomparisonacrosstheglobebasedoncurrentregionalregistryevidenceametaanalysisofreconstructedtimetoeventdata